Charles F. Sherrod IV, M.D., M.Sc.
@CharlesFoxIV
Followers
362
Following
3K
Media
17
Statuses
343
T32 CV Outcomes Research and General Cardiology Fellow @MidAmericaHeart via @BrownMedicine. Interested in health status, #HCM, and clinical trials.
Kansas City, MO
Joined December 2018
Congrats Omar!!.
Presented today @crfheart #NYValves2025 on the potential application of patient-reported health status (KCCQ) after M-TEER or TAVR.🫀🔧. Special thanks to my mentors @chetanhuded @jspertus @suzannevarnold. @saintlukeskc @MidAmericaHeart . 📸See attached photo for key points.
0
0
1
Congrats, Omar! Great news for patients and great mentorship from @AndrewJSauer.
At #ESCHF2025 🇷🇸 @MidAmericaHeart fellow Dr Omar Cantu-Martinez presents #CAREHKinHF real-world registry: >2,300 HF pts w/ hyperK risk with 9% on clinician selected patiromer. Reduced severe HK and trend toward more optimal GDMT. Take-home: early K⁺ control keeps GDMT on &
0
1
8
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
498
527
4K
RT @AndrewJSauer: Understanding patient-reported outcomes in obstructive hypertrophic cardiomyopathy (oHCM) is vital for managing treatment….
0
17
0
RT @stacyfarr: Congratulations TIARA Scholars implementing evidence into practice!.👏🏻.Today was the Certificate Ceremony & Keynote on the….
0
5
0
RT @AndrewJSauer: 📢 The Kansas City Cardiomyopathy Questionnaire (KCCQ-23) vs. NYHA Class in Obstructive Hypertrophic Cardiomyopathy. 🔹 our….
0
6
0
RT @ACCinTouch: .@stephencookmd, et al., conducted a voluntary survey of #ACCFITs & #ACCEarlyCareer cardiologists to evaluate #LGBTQ+ repre….
0
13
0
RT @BridgeBioPharma: We are excited to announce that the U.S. FDA approved our orally-administered near-complete (≥90%) stabilizer of TTR f….
0
42
0
RT @JAMACardio: Small mean treatment effects in heart failure trials may still lead to clinically meaningful improvements for a significant….
0
6
0
Congrats to @MAbdeljawadmd on this amazing study! @MidAmericaHeart.
Just presented at #AHA24: Interpreting Population Mean Treatment Effects in the Kansas City Cardiomyopathy Questionnaire, from JAMA Cardiology, free to read online
0
1
4
RT @JAMACardio: In this study, the Kansas City Cardiomyopathy Questionnaire (KCCQ) was a reliable and responsive measure of patient-reporte….
0
8
0
RT @MasriAhmadMD: An informative editorial by @MKIttlesonMD summarizing the background, context and findings from 4 studies in @JACCJournal….
0
18
0
RT @stacyfarr: US Maternal Mortality is alarmingly high and cardiovascular conditions are lead cause. ❤️🩹🩺🤰🏻.Our @HealthcareUMKC investig….
umkc.edu
$8.3 million grant is largest NIH award in university history
0
2
0
Congrats @DanNguyenCVO! @MidAmericaHeart.
Novel strategies to accelerate adoption of evidence into practice & cut the 17 year implementation gap are paramount. 💡🫀🤓.Proud of our work to improve shared decision making for chronic coronary disease. Kudos @DanNguyenCVO and team! .🙌🏻.
0
0
2
Congrats @MichaelNassifMD and @MidAmericaHeart !.
More winners of the HFC Excellence in Site-based Research Awards.For those who have demonstrated consistency in their hard work and received a previous SBR award. 🏆 Congrats to @MichaelNassifMD and Jackie Smith for their incredible work on MAPLE-HCM from @StLukesHealth
0
0
2
RT @American_Heart: We’ve got “Pink Pony Club” on repeat after @chappellroan’s win at the #VMAs. Congrats to the Best New Artist, and thank….
0
4
0
RT @AndrewJSauer: 🔥 📄 SEQUOIA-HCM 🔥 . @escardio #ESCCongress @JACCJournals . symptomatic oHCM.aficamten vs placebo.Improved KCCQ, 👇chest pa….
0
14
0
RT @KamalaHarris: Let’s be clear: Donald Trump would sign a national abortion ban and restrict access to contraception if given the chance.….
0
31K
0
Congrats @mirzakhan_ more work to be done!.
In Kansas City, 84.8% of out-of-hospital cardiac arrests happened at home. Among at-home OHCAs, 634 (49.1%) received bystander CPR and no patients had an AED applied despite nearby availability. Read more here.
0
0
2
RT @CircHF: The KCMO score: intuitive (% of ideal 💊), patient-centric, can adapt as guidelines ∆, ↑ granularity vs existing methods. The ne….
0
9
0
RT @NEJM: Presented at #HeartFailure2024: . Among patients with symptomatic obstructive hypertrophic cardiomyopathy, treatment with aficamt….
0
55
0